Phenotype and function of a CD56+ peripheral blood monocyte

Leukemia

Volumn 19, Issue 1, 2005, Pages 69-76

  Sconocchia, G ^a   Keyvanfar, K ^a   El Ouriaghli, F ^a   Grube, M ^a   Rezvani, K ^a   Fujiwara, H ^a   McCoy Jr , J P ^a   Hensel, N ^a   Barrett, A J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cellular differentiation; Cellular proliferation; Macrophages; Monocytes; NK cells

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD33 ANTIGEN; CD56 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; VIRUS ANTIGEN;

ADULT; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CELL STRAIN K 562; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 11844295984     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403550     Document Type: Article

References (40)

1. Edelman GM. Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol 1986; 2: 81-116.
2. Edelman GM. Morphoregulatory molecules. Biochemistry 1988; 27: 3533-3543.
3. Comeau MR, Van der Vuurst de Vries AR, Maliszewski CR, Galimbert L. CD123 bright plasmacytoid predendritic cells: progenitors undergoing cell fate coversion? J Immunol 2002; 169: 75-83.
4. Miller JS, Verfaillie C, McGlave P. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture. Blood 1992; 80: 2182-2187.
5. Mrozek E, Anderson P, Caligiuri MA. Role of Interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitors cells. Blood 1996; 87: 2632-2640.
6. Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M et al. G-CSF mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte. J Leuk Biol 2004; in press.
7. McKenzie D. Alloantigen presentation by B cells. J Immunol 1988; 141: 2907-2911.
8. Renauld JC, Vink A, VAN Snick J. Accessory signals in murine cytolytic T cell responses: dual requirement for IL-1 and IL-6. J Immunol 1989; 143: 1894-1898.
9. Kembala M, Uracz W, Ruggiero I, Mytar B, Pryjma J. Isolation and functional characteristics of FcR+ and FcR- human monocyte subsets. J Immunol 1984; 133: 1293-1299.
10. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulation of human natural killer cells defined by expression of the LEU-7 (HNK-1) and LEU-11 (NK-15) antigens. J Immunol 1983; 131 1789-1796.
11. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (LEU-11) and LEU-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136: 4480-4486.
12. Phillips JH, Lanier LL. Dissection of the lymphokine-activated killer phenomenon. J Exp Med 1986; 164: 814-825.
13. Ikushima S, Yoshihara T, Matsumura T, Misawa S, Morioka Y, Hibi S et al. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias. Int J Hematol 1991; 54: 395-403.
14. Raspaclori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 2001; 15: 1161-1164.
15. Petrella T, Comeau MR, Maynadie' M, Couillault G, De Muret A, Maliszewski CR et al. Agranular CD4+CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852-862.
16. Nitta T, Yagita H, Sato K, Okumura K. Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction. J Exp Med 1989; 170: 1757-1761.
17. Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N/CAM/CD56). J Immunol 1991; 12: 4421-4426.
18. Sconocchia G, Titus JA, Mazzoni A, Visintin A, Pericle F, Hicks SW et al. CD38 triggers cytotoxic responses in activated human natural killer cells. Blood 1999; 94: 3864-3871.
19. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid entity. Blood 1997; 90: 2417-2428.
20. Feuillard J, Jacob MC, Valensi F, Maynadie' M, Gressin R, Chaperot L et al. Clinical and biologic features of CD4+CD56+ malignancies. Blood 2003; 99: 1556-1563.
21. Penven K, Macro M, Salaun V, Comoz F, Reman O, Leroy D et al. Skin manifestation in CD4+CD56+ malignancies. Eur J Dermatol 2003; 13: 161-165.
22. Ziegler-Heitbrock HWL, Passlick B, Flieger D. The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocytes subsets in human peripheral blood. Hybridoma 1988; 7: 521-527.
23. Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74: 2527-2534.
24. Ziegler-Heitbrock HWL, Fingerle G, Strobel M, Schraut W, Stelter F, Schuett C et al. The novel subset of CD14+CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993; 23: 2053-2058.
25. high: a cytokine-producing monocytes subset expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25: 3418-3424.
26. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet 1997; 349: 692-695.
27. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168: 3536-3542.
28. Ziegler-Heitbrock HWL. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol Today 1999; 17 424-428.
29. Grage-Griebenow E, Zawatzky R, Kahlert H, Brade L, Flad HD, Ernst M. Identification of a novel dendritic cell-like subset of CD64+/CD16+ blood monocytes. Eur J Immunol 2001; 31: 48-56.
30. Keller R. Macrophage-mediated natural cytotoxicity against various target cells in vitro. II. Macrophages from rats of different ages. Br J Haematol 1978; 37: 742-746.
31. Tagliabue A, Mantovani A, Kilgallen M, Herberman RB, McCoy JL. Natural cytotoxicity of mouse monocytes and macrophages. J Immunol 1979; 122: 2363-2370.
32. Perri RT, Kay NE, McCarthy J, Vessella RL, Jacob HS, Furcht LT. Fibronectin enhances in vitro monocyte-macrophage-mediated tomoricidal activity. Blood 1982; 60: 430-435.
33. Andreesen R, Osterholz J, Bross KJ, Schulz A, Luckenbach GA, Lohr GW. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation. Cancer Res 1983; 43: 5931-5936.
34. Burns GF, Triglia T, Bartlett PF, Mackay IR. Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms. Proc Natl Acad Sci USA 1983; 80 7606-7610.
35. Ziegler-Heitbrock HWL, Riethmuller G. A rapid assay for cytotoxicity of unstimulated human monocytes. J Natl Cancer Inst 1984; 72: 23-29.
36. De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180: 1999-2004.
37. Zembala M, Uracz W, Ruggiero I, Mytar B, Pryjma J. Isolation and functional characteristics of FcR+ and FcR- human monocyte subsets. J Immunol 1984; 133: 1293-1299.
38. Hu X, Tang M, Fisher AB, Olashaw N, Zuckerman KS. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. J Immunol 1999; 163: 3106-3115.
39. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
40. Martin JHJ, Edwards SW. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. J Immunol 1993; 150: 3478-3486.